相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes
Jun-Sing Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
Alan Garber et al.
Endocrine Practice (2013)
Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells
Camilla Kappe et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Metformin: an old but still the best treatment for type 2 diabetes
Lilian Beatriz Aguayo Rojas et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Fixed-Dose Combinations for Treatment of Type 2 Diabetes Mellitus
Lawrence Blonde et al.
ADVANCES IN THERAPY (2012)
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Christoph Rosak et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2012)
Multidrug Treatment of Type 2 Diabetes A challenge for compliance
Roberto Miccoli et al.
DIABETES CARE (2011)
Use of Metformin in Patients with Kidney and Cardiovascular Diseases
David Klachko et al.
CARDIORENAL MEDICINE (2011)
Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
Olivia J. Phung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Metformin therapy and clinical uses
John H. B. Scarpello et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
Louis Monnier et al.
DIABETES CARE (2007)
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
M Hanefeld et al.
EUROPEAN HEART JOURNAL (2004)
Acarbose improves glycemic control in overweigh type 2 diabetic patients insufficiently treated with metformin
P Phillips et al.
DIABETES CARE (2003)
Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy
C Melikian et al.
CLINICAL THERAPEUTICS (2002)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study
S Halimi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2000)
分享论文
